Retail Pharmacy Chain — Business Valuation Multiple
EBITDA Valuation Guide · Small & Mid-Sized Businesses
Actual EBITDA multiples can vary materially based on EBITDA size, growth, recurring revenue, margins, customer concentration, owner dependence, geography and other company-specific factors.
Min
4×
Typical
5.5×
Max
7×
Revenue Model
Recurring
Capital Intensity
Medium
A typical multiple of 5.5× EBITDA reflects mid-market transactions in the $1–$50M revenue range.
Overview
Retail pharmacy chains typically trade at 4×–7× EBITDA at the multi-site operator level. Scale economies in NHS dispensing, private healthcare service diversification, and a loyal patient base with high footfall support valuations. Multi-site operators benefit from operational leverage and strategic acquirer interest. Government dispensing fee pressure and online pharmacy competition are the primary structural risks.
Key Value Drivers
- Scale economies in NHS dispensing
- Private healthcare service diversification
- Loyal patient base and footfall
- Operational leverage from multi-site portfolio
- Clinical pharmacist services income
Key Risks
- Government dispensing fee reduction
- Online pharmacy competition
- Regulatory change in dispensing model
- Locum pharmacist costs and shortage
- Drug margin compression
Disclaimer: All multiples are indicative estimates only and are not formal valuations or investment advice. They should not be relied upon for financial decision-making without independent professional advice.